tiprankstipranks
Paradigm Biopharmaceuticals Ltd. (AU:PAR)
:PAR
Australian Market

Paradigm Biopharmaceuticals Ltd. (PAR) Income Statement

Compare
22 Followers

Paradigm Biopharmaceuticals Ltd. Income Statement

Last quarter (Q4 2024), Paradigm Biopharmaceuticals Ltd.'s total revenue was AU$65.80K, an increase of 93.39% from the same quarter last year. In Q4, Paradigm Biopharmaceuticals Ltd.'s net income was AU$-9.69M. See Paradigm Biopharmaceuticals Ltd.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Jun 24Jun 23Jun 22Jun 21Jun 20
Total Revenue
AU$ 65.80KAU$ 46.76KAU$ 79.22KAU$ 20.55KAU$ 0.00
Gross Profit
AU$ 56.81KAU$ -125.72KAU$ -257.78KAU$ -288.65KAU$ -213.12K
Operating Expenses
AU$ 65.10MAU$ 59.09MAU$ 46.75MAU$ 42.06MAU$ 16.75M
Depreciation and Amortization
AU$ 146.74KAU$ 153.66KAU$ 193.25KAU$ 210.06KAU$ 213.12K
EBITDA
AU$ -64.54MAU$ -59.06MAU$ -46.82MAU$ -42.13MAU$ -15.70M
Operating Income
AU$ -65.11MAU$ -59.22MAU$ -47.01MAU$ -42.34MAU$ -16.96M
Other Income/Expenses
AU$ 411.88KAU$ 263.60KAU$ -1.48KAU$ -302.21KAU$ 1.01M
Pretax Income
AU$ -64.70MAU$ -58.95MAU$ -47.01MAU$ -42.65MAU$ -15.95M
Net Income
AU$ -58.65MAU$ -51.91MAU$ -39.25MAU$ -34.30MAU$ -12.30M
Per Share Metrics
AU$ ―AU$ ―AU$ ―AU$ ―AU$ ―
Basic EPS
AU$ -0.20AU$ -0.18AU$ -0.16AU$ -0.16AU$ -0.06
Diluted EPS
AU$ -0.20AU$ -0.18AU$ -0.16AU$ -0.16AU$ -0.06
Weighted Average Shares Outstanding
293.28M 289.68M 240.96M 212.19M 208.27M
Weighted Average Shares Outstanding (Diluted)
293.28M 289.68M 241.82M 212.19M 208.27M
Currency in AUD

Paradigm Biopharmaceuticals Ltd. Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis